GlassScriptPhysician profile
James Michael Melotek
NPI 1255696696
$4,206.49
in general payments reported to CMS, 2019-2025
24 companies · $52.42 in 2025
The $52.42 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $100 · 2021: $930 · 2022: $556 · 2023: $674 · 2024: $1,594 · 2025: $52.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Travel and Lodging: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.17 |
| Travel and Lodging | $995.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflexion Medical, INC. | $995.06 | 2024 | Reflexion Medical Radiotherapy System |
| Astrazeneca Pharmaceuticals LP | $418.63 | 2022-2023 | Imfinzi |
| Medtronic, INC. | $329.10 | 2021-2024 | Osteocool Rf Ablation System |
| Genzyme Corporation | $270.83 | 2021-2022 | |
| Axonics, INC. | $229.87 | 2023 | Axonics |
| E.R. Squibb & Sons, L.L.C. | $225.01 | 2020-2024 | Opdivo |
| Boston Scientific Corporation | $201.52 | 2023-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Novocure INC. | $143.12 | 2019-2025 | Optune, Optune Lua (Novottf-200t) |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2023 | Libtayo |
| Amgen INC. | $125.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $125.00 | 2021 | |
| Seagen INC. | $125.00 | 2023 | Adcetris |
| Dova Pharmaceuticals | $124.87 | 2021 | |
| Ethicon INC. | $120.00 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $109.38 | 2019 | |
| Glaxosmithkline, LLC. | $102.18 | 2021 | |
| Medline Industries LP | $82.66 | 2019 | |
| Myriad Genetic Laboratories, INC. | $55.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $54.46 | 2023-2025 | |
| Tactile Systems Technology INC | $48.02 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Ge Healthcare | $36.31 | 2021 | |
| Aurobindo Pharma USA, INC. | $20.16 | 2019 | |
| Fortovia Therapeutics, INC. | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Melotek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.